Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study

O'Sullivan, Sean S., Williams, David R., Gallagher, David A., Massey, Luke A., Silveira‐Moriyama, Laura, Lees, Andrew J.·2008·Movement Disorders

Cited by (290)

Items 101–200 of 290

  1. A Dual Centre Study of Pain in Parkinson’s Disease and Its Relationship with Other Non-Motor Symptoms
    Pritha Ghosh, Paola Imbriani, Nicoletta Caputi, Silvia Natoli, Tommaso Schirinzi, Giulia Di Lazzaro, Lindsey Covington, Andrew Dunn Sparks, Yekaterina Salnikova, Katarina Rukavina et al. · 2020 · Journal of Parkinson s Disease
  2. Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease
    Beat P. Müller, Jörg Aßmus, J. P. Larsen, Kristoffer Haugarvoll, GEIR OLVE SKEIE, Ole‐Bjørn Tysnes, the ParkWest study group · 2012 · Acta Neurologica Scandinavica
  3. Altered awareness of action in Parkinson’s disease: evaluations by explicit and implicit measures
    Naho Saito, Keisuke Takahata, Hodaka Yamakado, Nobukatsu Sawamoto, Satoshi Saitô, Ryōsuke Takahashi, Toshiya Murai, Hidehiko Takahashi · 2017 · Scientific Reports
  4. The Role of Mental Imagery in Parkinson’s Disease Rehabilitation
    Amit Abraham, Ryan P. Duncan, Gammon M. Earhart · 2021 · Brain Sciences
  5. Knowledge of Parkinson’s Disease in a Multiethnic Urban Asian Setting
    Ai Huey Tan, Chong Tin Tan, Connie Marras, Kwong Weng Loh, Niki Ho Wai Wye, Quan Hziung Lim, Pei Wen Tan, Chee Chean Lim, Yee Weai Cheong, Sik Thien Kong et al. · 2015 · Journal of Parkinson s Disease
  6. Response to Heat Pain Stimulation in Idiopathic Parkinson's Disease
    Ramachandiran Nandhagopal, André R. Troiano, Edwin Mak, Michael Schulzer, Mary Catherine Bushnell, Alexander Jon Stoessl · 2010 · Pain Medicine
  7. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
    Qi-wen Han, Yu‐He Yuan, Nai‐Hong Chen · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  8. Nonmotor symptom complex of Parkinson's disease--an under-recognized entity.
    Manmohan Mehndiratta, Rohit Garg, Sanjay Pandey · 2011 · PubMed
  9. Association of Parkinson’s disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-α
    Donghui Li, Xiangsheng Song, Huayun Huang, Huadong Huang, Zanya Ye · 2018 · Neuroscience Letters
  10. Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease
    Marianne van der Mark, Roel C.H. Vermeulen, Peter C.G. Nijssen, Wim M. Mulleners, Antonetta M. G. Sas, Teus van Laar, Anke Huss, Hans Kromhout · 2015 · Parkinsonism & Related Disorders
  11. Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study
    Rebecca Kerestes, Max A. Laansma, Conor Owens‐Walton, Andrew Perry, Eva M. van Heese, Sarah Al–Bachari, Tim Anderson, Francesca Assogna, Ítalo Karmann Aventurato, Tim D. van Balkom et al. · 2023 · Movement Disorders
  12. Prevalence of non-motor dysfunction among Parkinson's disease patients from a tertiary referral center in Mexico City
    Mayela Rodríguez‐Violante, Amin Cervantes‐Arriaga, Alejandra Villar-Velarde, Teresa Corona · 2010 · Clinical Neurology and Neurosurgery
  13. A clinical overview of non-motor symptoms in Parkinson's Disease.
    Nicola Modugno, Francesco Lena, Francesca Di Biasio, Gloria Cerrone, Stefano A. Ruggieri, Francesco Fornai · 2013 · PubMed
  14. Prevalence, Classification, and Etiology of Pain in Parkinson's Disease: Association between Parkinson's Disease and Fibromyalgia or Chronic Widespread Pain
    Katsuhiro Toda, Toshihide Harada · 2010 · The Tohoku Journal of Experimental Medicine
  15. Increase of Reproductive Life Span Delays Age of Onset of Parkinson’s Disease
    Dominik Frentzel, Grigorij Judanin, Olga Borozdina, Jochen Klucken, Jürgen Winkler, Johannes C. M. Schlachetzki · 2017 · Frontiers in Neurology
  16. Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson’s Disease, and Multiple Sclerosis: Diagnosis and Treatment
    Susan K. Conroy, Katherine B. Brownlowe, Thomas W. McAllister · 2020 · FOCUS The Journal of Lifelong Learning in Psychiatry
  17. Pain in Parkinson's disease: a neuroanatomy-based approach
    Domiziana Nardelli, Francesco Gambioli, Maria Ilenia De Bartolo, Romina Mancinelli, Francesca Biagioni, Simone Carotti, Emma Falato, Giorgio Leodori, Stefano Puglisi‐Allegra, Giorgio Vivacqua et al. · 2024 · Brain Communications
  18. Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease
    Xiaoxue Shi, Jinhua Zheng, Jianjun Ma, Zhidong Wang, Wenhua Sun, Mingjian Li, Shen Huang, Shiyu Hu · 2021 · Neurological Sciences
  19. Evaluation and management of the non-motor features of Parkinson’s disease
    Steven Wishart, Graeme J.A. Macphee · 2010 · Therapeutic Advances in Chronic Disease
  20. Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study
    Durrenberger, Pascal. F., Grünblatt, Edna, Fernando, Francesca S., Monoranu, Camelia Maria, Evans, Jordan, Riederer, Peter, Reynolds, Richard, Dexter, David T. · 2012 · Parkinson's Disease
  21. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson’s-Disease Model Mice
    Takahiro Fuchigami, Yutaka Itokazu, J. Morgan, Robert K. Yu · 2023 · Molecular Neurobiology
  22. Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence
    Roongroj Bhidayasiri, Daniel Dung Truong · 2011 · Parkinsonism & Related Disorders
  23. Changes in electrophysiological aperiodic activity during cognitive control in Parkinson’s disease
    Noémie Monchy, Julien Modolo, Jean‐François Houvenaghel, Bradley Voytek, Joan Duprez · 2024 · Brain Communications
  24. Nonmotor symptoms in Parkinson’s disease
    Anna Hussl, Klaus Seppi, Werner H Poewe · 2013 · Expert Review of Neurotherapeutics
  25. Characterizing mild cognitive impairment in prodromal Parkinson’s disease: A community‐based study in China
    Chenxi Pan, Yuqian Li, Jingru Ren, Lanting Li, Peiyu Huang, Pingyi Xu, Li Zhang, Wenbing Zhang, Minming Zhang, Jiu Chen et al. · 2021 · CNS Neuroscience & Therapeutics
  26. Increased likelihood of anxiety and poor sleep quality in Parkinson's disease patients with pain
    Abdul Qayyum Rana, Abdul Rehman Qureshi, Halima Bibi Kachhvi, Mohammad Abdullah Rana, Kelvin L. Chou · 2016 · Journal of the Neurological Sciences
  27. Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study
    Yu-Hsuan Wu, Wei‐Ju Lee, Yi-Huei Chen, Ming‐Hong Chang, Ching‐Heng Lin · 2016 · PLoS ONE
  28. Neuropathic Pain in Parkinson's Disease
    José Luis Cortes-Altamirano, Samuel Reyes-Long, Cindy Bandala, Abril Morraz-Varela, Herlinda Bonilla‐Jaime, Alfonso Alfaro-Rodríguez · 2022 · Neurology India
  29. Different diagnostic criteria for Parkinson disease: what are the pitfalls?
    Roongroj Bhidayasiri, Heinz Reichmann · 2013 · Journal of Neural Transmission
  30. Prediction of Parkinson’s disease subsequent to severe depression: a ten-year follow-up study
    Uwe Walter, Robert Heilmann, Lara Kaulitz, Tino Just, Bernd Joachim Krause, R. Benecke, Jacqueline Höppner · 2014 · Journal of Neural Transmission
  31. The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
    Do‐Young Kwon, Seong‐Beom Koh, Jae‐Hyeok Lee, Hee Kyung Park, Han‐Joon Kim, Hae‐Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim et al. · 2016 · Journal of Clinical Neurology
  32. Translation, adaptation and validation of the Bulgarian version of the King’s Parkinson’s Disease Pain Scale
    Galina Stoyanova-Piroth, Ivan Gospodinov Milanov, Katerina I. Stambolieva · 2021 · BMC Neurology
  33. Acupuncture Alleviated the Nonmotor Symptoms of Parkinson’s Disease including Pain, Depression, and Autonomic Symptoms
    Chifumi Iseki, Taiga Furuta, Masao Suzuki, Shingo Koyama, Keiji Suzuki, Tomoko Suzuki, Akiyo Kaneko, Tadamichi MITSUMA · 2014 · Case Reports in Neurological Medicine
  34. Sleep disturbance in Parkinson disease
    Samrat Roychowdhury, Duncan R. Forsyth · 2012 · Journal of Clinical Gerontology and Geriatrics
  35. Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson’s Disease Rat Model
    A. C. Campos, Miriã B. Berzuíno, G. R. Barbosa, Helena M R C Freire, Patricia S S Lopes, Danielle V. Assis, E. Fonoff, R. Pagano · 2021 · Cells
  36. How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson's disease?
    M. Rossi, S. Pérez-Lloret, M. Merello · 2021 · Parkinsonism & Related Disorders
  37. Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
    Chenxi Pan, Jingru Ren, Ping Hua, Lei Yan, Miao Yu, Yajie Wang, Gaiyan Zhou, Ronggui Zhang, Jiu Chen, Weiguo Liu · 2021 · Frontiers in Neuroscience
  38. Neuromodulation in Parkinson’s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach
    Md Reyaz Alam, Shamsher Singh · 2023 · Inflammopharmacology
  39. Predictive risk factors for chronic low back pain in Parkinson’s disease
    Erhan Arif Öztürk, Bilge Koçer · 2017 · Clinical Neurology and Neurosurgery
  40. Prevalence of non-motor symptoms in Parkinson's disease and its impact on quality of life in tertiary care center in India
    Balakrishnan Ramasamy, Madhavi Karri, Ramadoss Kalidoss · 2019 · Annals of Indian Academy of Neurology
  41. Nonmotor Effects of Conventional and Transdermal Dopaminergic Therapies in Parkinson's Disease.
    R. Kim, B. Jeon · 2017 · International review of neurobiology
  42. Burden of non-motor symptoms of Parkinson’s disease: cost-of-illness and quality-of-life estimates through a scoping review
    Frank van der Meer, Jesper Jørgensen, Mickaël Hiligsmann · 2024 · Expert Review of Pharmacoeconomics & Outcomes Research
  43. Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson’s Disease?
    Alan A. Baumeister · 2021 · Harvard Review of Psychiatry
  44. Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, Iran.
    Mehri Salari, Ahmad Chitsaz, Masoud Etemadifar, Mohammad Reza Najafi, Omid Mirmosayyeb, Maryam Bemanalizadeh, Fatemeh Panahi, Hosna Mirzajani · 2017 · PubMed Central
  45. Insulin-like growth factor in Parkinson’s disease is related to nonmotor symptoms and the volume of specific brain areas
    Xiaoxue Shi, Jinhua Zheng, Jianjun Ma, Zhidong Wang, Wenhua Sun, Mingjian Li, Shen Huang, Shiyu Hu · 2022 · Neuroscience Letters
  46. Presenting symptoms of GBA-related Parkinson's disease
    Nikola D. Kresojević, Milena Z. Janković, Igor N. Petrović, Kishore Raj Kumar, Nataša Dragašević, Valerija S. Dobričić, Ivana V. Novaković, Marina V. Svetel, Christine Klein, Tatjana D. Pekmezovic et al. · 2015 · Parkinsonism & Related Disorders
  47. Predictive model for health-related quality of life in patients with Parkinson's disease
    Sook Ja Lee, Sung Reul Kim, Sun Ju Chung, Hyun Chul Kang, Mi Sun Kim, Su Jin Cho, Hye Kyung Kwon, Jungwon Kim, Sun Young Jung · 2017 · Geriatric Nursing
  48. Mental Disturbances in Parkinson's Disease and Related Disorders: The Role of Excitotoxins
    Izabella Obál, Zsófia Majláth, József Toldi, László Vécsei · 2014 · Journal of Parkinson s Disease
  49. Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods
    Michaela Kaiserová, Zuzana Grambalova, Sandra Kurčová, Pavel Otruba, Hana Přikrylová Vranová, Kateřina Menšíková, Petr Kaňovský · 2021 · Biomedical Papers
  50. Pharmacological therapies for pain in Parkinson’s disease – a review paper
    Abdul Qayyum Rana, Danial Qureshi, Walid Sabeh, Abdullah Mosabbir, Eraad Rahman, Zainab Sarfraz, Ruqqiyah Rana · 2017 · Expert Review of Neurotherapeutics
  51. Negative impact of severity of pain on mood, social life and general activity in Parkinson’s disease
    Abdul Qayyum Rana, Abdul Rehman Qureshi, Asna Haris, Muhammad Affan Danish, Muhammad Saad Furqan, Omar Mohammad Shaikh, Zainab Sarfraz, Ruqqiyah Rana · 2018 · Neurological Research
  52. Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders
    Oritoke M. Aluko, Joy D. Iroegbu, Omamuyovwi Meashack Ijomone, Solomon Umukoro · 2021 · Clinical Psychopharmacology and Neuroscience
  53. Recognition and management of Parkinson’s disease during the premotor (prodromal) phase
    Daniel D. Truong, Erik Ch. Wolters · 2009 · Expert Review of Neurotherapeutics
  54. The Inflammatory Cytokines in the Pathogenesis of Parkinson’s Disease
    Hanaa L. Sadek · 2014 · Journal of Alzheimer’s Disease & Parkinsonism
  55. Quantitative Sensory Testing (QST) in Drug-Naïve Patients with Parkinson’s Disease
    Odette Fründt, Wiebke Grashorn, Carsten Buhmann, Katarina Forkmann, Tina Mainka, Ulrike Bingel, Katharina Schmidt · 2019 · Journal of Parkinson s Disease
  56. Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism—comparison with values from healthy volunteers
    Rachid Fahmi, Günther Platsch, Alexandre Bani Sadr, Sylvain Gouttard, Stéphane Thobois, Sven Zuehlsdorff, Christian Scheiber · 2020 · European Journal of Hybrid Imaging
  57. Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease
    Maryann N. Krasko, John C. Szot, Karolina Lungova, Linda M. Rowe, GLEN E. LEVERSON, Cynthia A. Kelm‐Nelson, Michelle R. Ciucci · 2023 · Dysphagia
  58. The role of orexin in Parkinson's disease
    Alisha Braun, Jim Manavis, Akihiro Yamanaka, Youichirou Ootsuka, Peter Charles Blumbergs, Larisa Bobrovskaya · 2024 · Journal of Neuroscience Research
  59. Nonmotor Aspects of Parkinson's Disease
    EDUARDO S. TOLOSA, Joan Santamaría, Carles Gaig, Yaroslau Compta · 2009 · Blue books of neurology
  60. The heterogeneity of non-motor symptoms of Parkinson’s disease
    Ning Zhang, Weiguo Liu, Min Ye, Alexander D. Cohen, Yingdong Zhang · 2014 · Neurological Sciences
  61. NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE
    Marina Romanovna Nodel, Nikolay N. Yakhno · 2009 · Neurology neuropsychiatry Psychosomatics
  62. Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson’s disease
    Işıl Ezgi Eryılmaz, Sevda Erer, Mehmet Zarifoğlu, Ünal Egelí, Ece Karakuş, Beste Yurdacan, Gülşah Çeçener, Berrin Tunca, Beril Dönmez Çolakoğlu, Ayşe Bora Tokçaer et al. · 2020 · Clinical Neurology and Neurosurgery
  63. Clinical and Non-Clinical Cardiovascular Disease Associated Pathologies in Parkinson’s Disease
    Bonn Lee, Charlotte E. Edling, Shiraz Ahmad, Fiona E. N. LeBeau, Gary Tse, Kamalan Jeevaratnam · 2023 · International Journal of Molecular Sciences
  64. Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records
    Shaohua Lyu, Claire Shuiqing Zhang, Zhenhui Mao, Xinfeng Guo, Zhe Li, Xiaodong Luo, Jingbo Sun, Qiaozhen Su · 2024 · Frontiers in Aging Neuroscience
  65. Lipids in the Treatment of Neurodegenerative Diseases
    Klaus W. Lange · 2020 · Wiley eBooks
  66. Is there a need to redefine Parkinson’s disease?
    Philipp Mahlknecht, Werner H Poewe · 2013 · Journal of Neural Transmission
  67. Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys
    Maria Gabriela de Brito Sanchez, Marc Morissette, Thérèse Di Paolo · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  68. Cognitive and behavioral assessment in Parkinson’s disease
    Saül Martínez‐Horta, Andrea Horta‐Barba, Jaime Kulisevsky · 2019 · Expert Review of Neurotherapeutics
  69. Impaired pain processing in Parkinson's disease and its relative association with the sense of smell
    Takashi Hara, Masaaki Hirayama, Yasuaki Mizutani, Tetsuo Hama, Norio Hori, Tomohiko Nakamura, Shigenori Kato, Hirohisa Watanabe, Gen Sobue · 2012 · Parkinsonism & Related Disorders
  70. Osteoarthritis Increases Paresthestic and Akathisic Pain, Anxiety Case-ness, and Depression Severity in Patients With Parkinson's Disease
    Abdul Qayyum Rana, Abdul Rehman Qureshi, Shakib Akhter, Yameen Ingar, Ayub Ali, Ismael Y. Abdullah, Obaidullah Madhosh, Zainab Sarfraz, Muhammad B. Rana, Ruqqiyah Rana · 2018 · Frontiers in Neurology
  71. A Community-Based Program for Exercise and Social Participation for Individuals With Parkinson's Disease: A Multidisciplinary Model
    Gemma Moya‐Galé, Amerigo Rossi, Rebecca A. States · 2020 · Perspectives of the ASHA Special Interest Groups
  72. Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson’s Disease
    Karina Henrique Binda, Marucia Chacur, Daniel Oliveira Martins · 2023 · Neurotoxicity Research
  73. New insights on the mitochondrial proteome plasticity in Parkinson's disease
    Miguel Aroso, Rita M. Ferreira, Ana Freitas, Rui Miguel Pinheiro Vitorino, María Gómez-Lázaro · 2016 · PROTEOMICS - CLINICAL APPLICATIONS
  74. Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review
    Iris van der Lijn, Gera A. de Haan, Famke Huizinga, Fleur E. van der Feen, A. Wijnand F. Rutgers, Catherina Stellingwerf, Teus van Laar, Joost Heutink · 2022 · Journal of Parkinson s Disease
  75. Gastrointestinale Störungen beim idiopathischen Parkinson-Syndrom
    Kelly Del Tredici, Wolfgang H. Jost · 2012 · Der Nervenarzt
  76. Urolithin A improves Parkinson's disease-associated cognitive impairment through modulation of neuroinflammation and neuroplasticity
    Ning Xu, Chenchen Du, Yu Jing Yuan, Yan Li, Shixuan Gao, Shuyan Yu, Baozhu Sun, Haiyan Lou · 2025 · Experimental Neurology
  77. Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens
    Luisa Franck, Lisa Hahnefeld, Lucie Valek, Katharina Klatt‐Schreiner, Annett Wilken‐Schmitz, Mohamad Wessam Alnouri, Sandra Trautmann, Marc-Philipp Weyer, Dominique Thomas, Robert Gurke et al. · 2025 · npj Parkinson s Disease
  78. Predictors and Level of Knowledge Regarding Parkinson's Disease among Patients: A Cross-sectional Study from Thailand
    Pramon Viwattanakulvanid, Ratana Somrongthong, Muskan Vankwani, F N Kavita, Ramesh Kumar · 2020 · International Journal of Preventive Medicine
  79. Potential protective role of astrocytes in the pathogenesis of astrocyte-mediated synaptic plasticity of Parkinson’s disease
    Yuqi Zhang, Kangrong Lu · 2021 · Journal of Integrative Neuroscience
  80. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease
    Pauli Seppänen, Markus Forsberg, Miia Tiihonen, Heikki Laitinen, Selena Beal, David C. Dorman · 2024 · Parkinson s Disease
  81. Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review
    Regina H. Silva, Leonardo B. Lopes-Silva, D. G. Cunha, Marcela S. Becegato, Alessandra Mussi Ribeiro, Jordão Rita de Cassia Martins dos Santos · 2024 · Brain Sciences
  82. The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson’s Disease
    Tal Ben Shaul, Dan Frenkel, Tanya Gurevich · 2024 · International Journal of Molecular Sciences
  83. Validation of a non-motor fluctuations questionnaire in Parkinson's disease
    Florent Faggianelli, Anderson Loundou, Karine Baumstarck, S. Nathalie, Pascal Auquier, Alexandre Eusébio, Luc Defebvre, Christine Brefel‐Courbon, Jean‐Luc Houéto, David Maltête et al. · 2021 · Revue Neurologique
  84. Nonmotor symptoms in Parkinson's disease: classification and management
    Roberto Erro, Gabriella Santangelo, Paolo Barone, Carmine Vitale · 2015 · Journal of Parkinsonism and Restless Legs Syndrome
  85. Depression in Parkinson's disease
    Marina Romanovna Nodel, Marina Romanovna Nodel · 2010 · Neurology neuropsychiatry Psychosomatics
  86. Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease
    Marina Picillo, Paolo Barone, Maria Teresa Pellecchia · 2017 · Movement Disorders Clinical Practice
  87. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
    Sacnité Albarrán‐Bravo, José Arturo Ávalos‐Fuentes, Hernán Cortés, Marina Rodríguez-Sánchez, Norberto Leyva‐García, Claudia Rangel‐Barajas, David Erlij, Benjamí­n Florán · 2019 · Biomolecules
  88. Predictive modeling to uncover Parkinson’s disease characteristics that delay diagnosis
    Tom Hähnel, Tamara Raschka, Jochen Klucken, Enrico Glaab, Jean‐Christophe Corvol, Björn H. Falkenburger, Holger Fröhlich · 2025 · npj Parkinson s Disease
  89. Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects
    Maria Teresa Pellecchia, Marina Picillo, Marcello Moccia, Emanuele Spina, Paolo Barone · 2016 · Journal of Parkinsonism and Restless Legs Syndrome
  90. Erken Evre Parkinson Hastalığında Motor Olmayan Semptomların Değerlendirilmesi
    Haluk Gümüş, Zehra Akpınar, Orhan Demir · 2013 · Turkish Journal Of Neurology
  91. Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson’s disease
    Mubasher A. Qamar, Phoebe Tall, Daniel J. van Wamelen, Yi-Min Wan, Katarina Rukavina, Anna Fieldwalker, Donna Matthew, Valentina Leta, Kirsty Bannister, К. Ray Chaudhuri · 2023 · International review of neurobiology
  92. Historical perspectives on the discovery and development of drugs to treat neurological disorders
    Michael J. Williams, JOSEPH T. COYLE · 2012 · Cambridge University Press eBooks
  93. Sleep in Parkinson’s Disease
    Anjali Gera, Cynthia L. Comella · 2022 · Springer eBooks
  94. Sex differences in the severity of non-motor symptoms in Parkinson’s disease: a systematic review and meta-analysis
    Calogero Edoardo Cicero, Claudio Terravecchia, Lavinia Lucia Pettinato, Silvia Maria Rita Tabbì, Giulia Donzuso, Donatella Contrafatto, Giovanni Mostile, Mario Zappia, Alessandra Susie Quesado Nicoletti · 2026 · npj Parkinson s Disease
  95. “Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”
    Garima Sharma, Badruddeen Badruddeen, Juber Akhtar, Mohammad Irfan Khan, Mohammad Kaleem Ahmad, Prakash Kumar Sharma · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  96. Mixed anxiety-depressive disorder in Parkinson's disease associated with worse resting state functional response to deep brain stimulation of subthalamic nucleus
    Pavel Filip, Andrej Lasica, Tereza Uhrová, Josef Mana, Filip Růžička, Jiří Keller, Karsten Mueller, Kristína Burdová, Dimitra Kiakou, Robert Jech · 2024 · Heliyon
  97. Características epidemiológicas de pacientes con enfermedad de Parkinson de un hospital de referencia en México
    Mayela Rodríguez‐Violante, Alejandra Villar-Velarde, Cristopher Valencia-Ramos, Amin Cervantes‐Arriaga · 2011
  98. Manejo de la disfunción autonómica en la enfermedad de Parkinson
    José Antonio Crespo-Burillo, Raquel Alarcia Alejos · 2015 · Revista de Neurología
  99. The Natural History of Parkinson’s Disease
    Miguel M Coelho, Joaquim José Ferreira · 2017 · Springer eBooks
  100. Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson’s Disease (ARPD): PLA2G6 and Other Gene Loci
    Renjitha Gopurappilly · 2021 · Advances in experimental medicine and biology